Pub. Date : 2020 May 20
PMID : 32443710
9 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | Thalidomide Reduces Vascular Endothelial Growth Factor Immunostaining in Canine Splenic Hemangiosarcoma. | Thalidomide | vascular endothelial growth factor A | Canis lupus familiaris |
| 2 | Recently it was demonstrated that thalidomide extends the survival time of dogs with HSA, potentially due to thalidomide-induced inhibition of vascular endothelial growth factor (VEGF) production by the neoplastic cells. | Thalidomide | vascular endothelial growth factor A | Canis lupus familiaris |
| 3 | Recently it was demonstrated that thalidomide extends the survival time of dogs with HSA, potentially due to thalidomide-induced inhibition of vascular endothelial growth factor (VEGF) production by the neoplastic cells. | Thalidomide | vascular endothelial growth factor A | Canis lupus familiaris |
| 4 | Recently it was demonstrated that thalidomide extends the survival time of dogs with HSA, potentially due to thalidomide-induced inhibition of vascular endothelial growth factor (VEGF) production by the neoplastic cells. | Thalidomide | vascular endothelial growth factor A | Canis lupus familiaris |
| 5 | Recently it was demonstrated that thalidomide extends the survival time of dogs with HSA, potentially due to thalidomide-induced inhibition of vascular endothelial growth factor (VEGF) production by the neoplastic cells. | Thalidomide | vascular endothelial growth factor A | Canis lupus familiaris |
| 6 | To investigate this, immunostaining was used to evaluate VEGF within HSA metastases that developed after thalidomide treatment. | Thalidomide | vascular endothelial growth factor A | Canis lupus familiaris |
| 7 | This supports the hypothesis that thalidomide prolongs survival time in dogs with HSA due to inhibition of VEGF production by the neoplastic cells. | Thalidomide | vascular endothelial growth factor A | Canis lupus familiaris |
| 8 | As VEGF remained visible within HSAs exposed to thalidomide, additional treatments to inhibit VEGF production may further prolong survival times of dogs with these common canine neoplasms. | Thalidomide | vascular endothelial growth factor A | Canis lupus familiaris |
| 9 | As VEGF remained visible within HSAs exposed to thalidomide, additional treatments to inhibit VEGF production may further prolong survival times of dogs with these common canine neoplasms. | Thalidomide | vascular endothelial growth factor A | Canis lupus familiaris |